Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients

NCT01783834 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Previous Treated Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: Gefitinib
DRUG: Pemetrexed

Sponsor

Gachon University Gil Medical Center